About Hemab
Hemab is a company based in Copenhagen (Denmark) founded in 2019.. Hemab has raised $309.92 million across 4 funding rounds from investors including RA Capital, Deep Track Capital and Avoro Capital Advisors. The company has 10 employees as of December 31, 2022. Hemab offers products and services including HMB-001 and HMB-002. Hemab operates in a competitive market with competitors including Varmx, AbFero Pharmaceuticals, Alveron Pharma, TargED and Pangen Biotech, among others.
- Headquarter Copenhagen, Denmark
- Employees 10 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
$-22.15 M (USD)-345as on Dec 31, 2022
-
EBITDA
$-22.84 M (USD)-302as on Dec 31, 2022
-
Total Equity Funding
$309.92 M (USD)
in 4 rounds
-
Latest Funding Round
$157 M (USD), Series C
Oct 27, 2025
-
Investors
RA Capital
& 9 more
-
Employee Count
10
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemab
Hemab offers a comprehensive portfolio of products and services, including HMB-001 and HMB-002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibody that stabilizes factor VIIa for bleeding disorder treatment
Antibody for preventing bleeding in Von Willebrand Disease
Unlock access to complete
Unlock access to complete
Funding Insights of Hemab
Hemab has successfully raised a total of $309.92M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $157 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $157.0M
-
First Round
First Round
(20 Nov 2020)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series C - Hemab | Valuation | Sofinnova Partners | |
| Feb, 2023 | Amount | Series B - Hemab | Valuation | Access Industries | |
| Jul, 2021 | Amount | Series A - Hemab | Valuation | Novo Holdings , Healthcap |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hemab
Hemab has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Deep Track Capital and Avoro Capital Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep Track Capital is engaged in biotechnology investment activities.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on biotechnology startups
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward ESG-focused companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hemab
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hemab
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hemab Comparisons
Competitors of Hemab
Hemab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Varmx, AbFero Pharmaceuticals, Alveron Pharma, TargED and Pangen Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic proteins are developed to restore blood clotting in patients.
|
|
| domain | founded_year | HQ Location |
Oral iron chelators are developed for iron overload disease treatment.
|
|
| domain | founded_year | HQ Location |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| domain | founded_year | HQ Location |
Biological drugs for thrombosis treatment are developed by the company.
|
|
| domain | founded_year | HQ Location |
Developer of biosimilars and biologics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hemab
Frequently Asked Questions about Hemab
When was Hemab founded?
Hemab was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Hemab located?
Hemab is headquartered in Copenhagen, Denmark.
Is Hemab a funded company?
Hemab is a funded company, having raised a total of $309.92M across 4 funding rounds to date. The company's 1st funding round was a Series A of $14.96M, raised on Nov 20, 2020.
How many employees does Hemab have?
As of Dec 31, 2022, the latest employee count at Hemab is 10.
What does Hemab do?
Hemab was founded in 2019 in Copenhagen, Denmark, within the biotechnology sector. Novel antibody-based therapies are developed by the company to modulate the bodys clotting pathway, either by stabilizing or inhibiting clotting factors. These treatments target unmet needs in rare bleeding and thrombotic disorders, with a pipeline of candidates aimed at prophylactic options and potential functional cures. Operations focus on addressing life-threatening complications for affected patients.
Who are the top competitors of Hemab?
Hemab's top competitors include Varmx, Cadrenal Therapeutics and Alveron Pharma.
What products or services does Hemab offer?
Hemab offers HMB-001 and HMB-002.
Who are Hemab's investors?
Hemab has 10 investors. Key investors include RA Capital, Deep Track Capital, Avoro Capital Advisors, Maj Invest, and Rock Springs Capital.